• Something wrong with this record ?

Effect of aqueous extract and anthocyanins of calyces of Hibiscus sabdariffa (Malvaceae) in rats with adenine-induced chronic kidney disease

BH. Ali, L. Cahliková, L. Opletal, T. Karaca, P. Manoj, A. Ramkumar, YM. Al Suleimani, M. Al Za'abi, A. Nemmar, L. Chocholousova-Havlikova, M. Locarek, T. Siatka, G. Blunden,

. 2017 ; 69 (9) : 1219-1229. [pub] 20170523

Language English Country England, Great Britain

Document type Comparative Study, Journal Article

Persistent link   https://www.medvik.cz/link/bmc18024993

OBJECTIVES: The aim of this work was to assess the possible beneficial effects of aqueous extracts of Hibiscus sabdariffa L. calyces and anthocyanins isolated therefrom in an adenine-induced chronic kidney disease (CKD) model. METHODS: Rats were orally given, for 28 consecutive days, either adenine alone or together with either aqueous extract of H. sabdariffa calyces (5 and 10%) or anthocyanins (50, 100 and 200 mg/kg of anthocyanin concentrate). For comparative purposes, two groups of rats were given lisinopril (10 mg/kg). KEY FINDINGS: When either H. sabdariffa aqueous extract or the anthocyanins isolated from it was administered along with adenine, the adverse effects of adenine-induced CKD were significantly lessened, mostly in a dose-dependent manner. The positive effects were similar to those obtained by administration of lisinopril. CONCLUSIONS: The results obtained show that both H. sabdariffa and its anthocyanins could be considered as possible promising safe dietary agents that could be used to attenuate the progression of human CKD. This could have added significance as H. sabdariffa tea is widely consumed in many parts of Africa and Asia and is thus readily available.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18024993
003      
CZ-PrNML
005      
20180711093217.0
007      
ta
008      
180709s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/jphp.12748 $2 doi
035    __
$a (PubMed)28542915
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Ali, Badreldin H $u Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Al Khod, Oman.
245    10
$a Effect of aqueous extract and anthocyanins of calyces of Hibiscus sabdariffa (Malvaceae) in rats with adenine-induced chronic kidney disease / $c BH. Ali, L. Cahliková, L. Opletal, T. Karaca, P. Manoj, A. Ramkumar, YM. Al Suleimani, M. Al Za'abi, A. Nemmar, L. Chocholousova-Havlikova, M. Locarek, T. Siatka, G. Blunden,
520    9_
$a OBJECTIVES: The aim of this work was to assess the possible beneficial effects of aqueous extracts of Hibiscus sabdariffa L. calyces and anthocyanins isolated therefrom in an adenine-induced chronic kidney disease (CKD) model. METHODS: Rats were orally given, for 28 consecutive days, either adenine alone or together with either aqueous extract of H. sabdariffa calyces (5 and 10%) or anthocyanins (50, 100 and 200 mg/kg of anthocyanin concentrate). For comparative purposes, two groups of rats were given lisinopril (10 mg/kg). KEY FINDINGS: When either H. sabdariffa aqueous extract or the anthocyanins isolated from it was administered along with adenine, the adverse effects of adenine-induced CKD were significantly lessened, mostly in a dose-dependent manner. The positive effects were similar to those obtained by administration of lisinopril. CONCLUSIONS: The results obtained show that both H. sabdariffa and its anthocyanins could be considered as possible promising safe dietary agents that could be used to attenuate the progression of human CKD. This could have added significance as H. sabdariffa tea is widely consumed in many parts of Africa and Asia and is thus readily available.
650    _2
$a adenin $x toxicita $7 D000225
650    _2
$a aplikace orální $7 D000284
650    _2
$a zvířata $7 D000818
650    _2
$a anthokyaniny $x aplikace a dávkování $x izolace a purifikace $x farmakologie $7 D000872
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a Hibiscus $x chemie $7 D031584
650    _2
$a lisinopril $x farmakologie $7 D017706
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a rostlinné extrakty $x aplikace a dávkování $x farmakologie $7 D010936
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a chronická renální insuficience $x farmakoterapie $x patofyziologie $7 D051436
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a Cahliková, Lucie $u ADINACO Research Group, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic.
700    1_
$a Opletal, Lubomir $u ADINACO Research Group, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic.
700    1_
$a Karaca, Turan $u Department of Histology-Embryology, Faculty of Medicine, University of Trakya, Edirne, Turkey.
700    1_
$a Manoj, Priyadarsini $u Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Al Khod, Oman.
700    1_
$a Ramkumar, Aishwarya $u Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Al Khod, Oman.
700    1_
$a Al Suleimani, Yousuf M $u Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Al Khod, Oman.
700    1_
$a Al Za'abi, Mohammed $u Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Al Khod, Oman.
700    1_
$a Nemmar, Abderrahim $u Department of Physiology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, UAE.
700    1_
$a Chocholousova-Havlikova, Lucie $u Department of Analytical Chemistry, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic.
700    1_
$a Locarek, Miroslav $u ADINACO Research Group, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic.
700    1_
$a Siatka, Tomas $u ADINACO Research Group, Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic.
700    1_
$a Blunden, Gerald $u School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, Hampshire, UK.
773    0_
$w MED00002901 $t The Journal of pharmacy and pharmacology $x 2042-7158 $g Roč. 69, č. 9 (2017), s. 1219-1229
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28542915 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20180711093508 $b ABA008
999    __
$a ok $b bmc $g 1317124 $s 1021914
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 69 $c 9 $d 1219-1229 $e 20170523 $i 2042-7158 $m Journal of pharmacy and pharmacology $n J Pharm Pharmacol $x MED00002901
LZP    __
$a Pubmed-20180709

Find record

Citation metrics

Archiving options